Relevant bibliographies by topics / Tumor necrosis factor

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Tumor necrosis factor'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tumor necrosis factor.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tumor necrosis factor"

1

KEYSTONE, E. C., and C. F. WARE. "Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies." Journal of Rheumatology Supplement 85 (May 1, 2010): 27–39. http://dx.doi.org/10.3899/jrheum.091463.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chung, Phil-Sang, та Pil-Seob Jeong. "Antitumor effect of Tumor Necrosis Factor-α". Journal of Clinical Otolaryngology Head and Neck Surgery 7, № 1 (1996): 45–55. http://dx.doi.org/10.35420/jcohns.1996.7.1.45.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Inoue, Mamoru, Hidetoshi Inoko, and Kimiyoshi Tsuji. "Tumor necrosis factor." Ensho 12, no. 1 (1992): 21–32. http://dx.doi.org/10.2492/jsir1981.12.21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Old, Lloyd J. "Tumor Necrosis Factor." Scientific American 258, no. 5 (1988): 59–75. http://dx.doi.org/10.1038/scientificamerican0588-59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wenzel, Richard P., Roger C. Bone, and Michel P. Glauser. "Tumor necrosis factor." Critical Care Medicine 21, Supplement (1993): S414–422. http://dx.doi.org/10.1097/00003246-199310001-00001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

TRACEY, KEVIN J., and ANTHONY CERAMI. "Tumor necrosis factor." Critical Care Medicine 21, Supplement (1993): S423–435. http://dx.doi.org/10.1097/00003246-199310001-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vilcek, J., and T. H. Lee. "Tumor necrosis factor." Journal of Biological Chemistry 266, no. 12 (1991): 7313–16. http://dx.doi.org/10.1016/s0021-9258(20)89445-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chu, Wen-Ming. "Tumor necrosis factor." Cancer Letters 328, no. 2 (2013): 222–25. http://dx.doi.org/10.1016/j.canlet.2012.10.014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Duerrschmid, Clemens, JoAnn Trial, Yanlin Wang, Mark L. Entman, and Sandra B. Haudek. "Tumor Necrosis Factor." Circulation: Heart Failure 8, no. 2 (2015): 352–61. http://dx.doi.org/10.1161/circheartfailure.114.001893.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Varfolomeev, Eugene E., and Avi Ashkenazi. "Tumor Necrosis Factor." Cell 116, no. 4 (2004): 491–97. http://dx.doi.org/10.1016/s0092-8674(04)00166-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Tumor necrosis factor"

1

Björnberg, Flemming. "Processing of TNF-receptors to soluble receptor forms in myeloid cells." Lund : Dept. of Hematology, Lund University, 1998. http://catalog.hathitrust.org/api/volumes/oclc/39176479.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Engelberts, Ingeborg. "Tumor necrosis factor during sepsis king of cytokines? /." Maastricht : Maastricht : Universitaire Pers Maastricht ; University Library, Maastricht University [Host], 1994. http://arno.unimaas.nl/show.cgi?fid=6955.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Krugten, Michiel Volkert van. "Tumor necrosis factor gene polymorphisms and rheumatic diseases /." Leiden, 2003. http://catalogue.bnf.fr/ark:/12148/cb40223074h.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Oukacha, Khadija. "Perturbation chimique du transport de Tumor Necrosis Factor." Electronic Thesis or Diss., Université Paris sciences et lettres, 2023. http://www.theses.fr/2023UPSLS067.

Full text
Abstract:
Alors qu'il est essentiel pour lutter contre les agents pathogènes, TNF (Tumor Necrosis factor) secrété́ en excès devient nocif pour l'organisme comme dans le cas de maladies inflammatoires chroniques (polyarthrite rhumatoïde ou maladie de Crohn). Les thérapies actuelles sont basées sur des injections récurrentes d'anti-TNF contre lesquelles 30% des patients développent une résistance. Il existe donc un fort besoin de composés chimiques réduisant la sécrétion de TNF. Nous avons exploité la diversité́ des voies de sécrétion dépendantes de l’appareil de Golgi pour identifier des molécules inhiba
APA, Harvard, Vancouver, ISO, and other styles
5

Watts, Alan D. "The biological role of transmembrane tumour necrosis factor [alpha]." Thesis, The University of Sydney, 1998. https://hdl.handle.net/2123/27668.

Full text
Abstract:
Tumour necrosis factor (TNF) exists in two physiological forms. One is a soluble polypeptide of 17 kDa, and the other a type II integral membrane protein of 26 kDa designated transmembrane TNF. Soluble TNF is derived from the transmembrane form by proteolytic processing. The soluble TNF molecule exerts potent cytotoxic activity against certain types of cancer cells, and plays a critical role in the functioning of the immune and inflammatory system. The transmembrane TNF molecule shares many of the properties of the soluble form in vitro, but its function in the immune system is not as c
APA, Harvard, Vancouver, ISO, and other styles
6

Langton, Amy Jean. "The role of TRUSS in TNFα-TNFRI signalling : implications for inflammatory lung diseases". Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.608019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Atkinson, Yvelle Hope. "Regulation of neutrophil functions by tumor necrosis factor-alpha /." Title page, contents and summary only, 1989. http://web4.library.adelaide.edu.au/theses/09PH/09pha878.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bond, Arden Lenore. "The production and characterization of a putative anti-idiotypic antibody to tumor necrosis factor-[alpha] /." This resource online, 1992. http://scholar.lib.vt.edu/theses/available/etd-05042010-020132/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tan, Ern Yu. "Loss of protein folding gene expression in human tumors." Thesis, University of Oxford, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.670106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Han, Jiahuai. "Study of the regulation of cachectin/tumor necrosis factor expression." Doctoral thesis, Universite Libre de Bruxelles, 1990. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/213139.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Tumor necrosis factor"

1

Corti, Angelo, and Pietro Ghezzi. Tumor Necrosis Factor. Humana Press, 2004. http://dx.doi.org/10.1385/1592597718.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

National Institutes of Health (U.S.), ed. Tumor necrosis factor. National Institutes of Health, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

National Institutes of Health (U.S.), ed. Tumor necrosis factor. National Institutes of Health, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sanjay, Khare, ed. TNF superfamily. Landes Bioscience, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Angelo, Corti, and Ghezzi P, eds. Tumor necrosis factor: Methods and protocols. Humana Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sanjay, Khare, ed. TNF superfamily. Landes Bioscience, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gregory, Bock, Marsh Joan, and Symposium on Tumour Necrosis Factor and Related Cytotoxins (1987 : London, England), eds. Tumour necrosis factor and related cytotoxins. Wiley, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

F, Oettgen Herbert, and International Cancer Research Data Bank., eds. Selected abstracts on tumor necrosis factor. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, International Cancer Research Data Bank, National Cancer Institute, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bruce, Beutler, ed. Tumor necrosis factors: The molecules and their emerging role in medicine. Raven Press, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Benjamin, Bonavida, ed. Tumor necrosis factor/cachectin and related cytokines. Karger, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Tumor necrosis factor"

1

Chu, Wen-Ming. "Tumor Necrosis Factor." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_6040-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Barger, Steven W. "Tumor Necrosis Factor." In Neuroprotective Signal Transduction. Humana Press, 1998. http://dx.doi.org/10.1007/978-1-59259-475-7_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chu, Wen-Ming. "Tumor Necrosis Factor." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-46875-3_6040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ulich, Thomas R. "Tumor Necrosis Factor." In Cytokines of the Lung. CRC Press, 2022. http://dx.doi.org/10.1201/9781003066927-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Manogue, Kirk R., and Anthony Cerami. "Cachectin (Tumor Necrosis Factor)." In Cellular and Molecular Aspects of Inflammation. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5487-1_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Brightling, Christopher, Latifa Chachi, Dhan Desai, and Yassine Amrani. "Tumor Necrosis Factor Alpha." In Inflammation and Allergy Drug Design. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444346688.ch18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Johnson, Victor J. "Tumor Necrosis Factor-α." In Encyclopedia of Immunotoxicology. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-54596-2_1522.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Arampatzis, Adamantios, Lida Mademli, Thomas Reilly, et al. "Tumor Necrosis Factor Alpha." In Encyclopedia of Exercise Medicine in Health and Disease. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_3152.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Papp, K. A., and Mathew N. Nicholas. "Tumor Necrosis Factor Inhibition." In Biologic and Systemic Agents in Dermatology. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-66884-0_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Johnson, Victor J. "Tumor Necrosis Factor-α." In Encyclopedia of Immunotoxicology. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27786-3_1522-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Tumor necrosis factor"

1

Goel, Raghav, Guilio F. Paciotti, and John C. Bischof. "Tumor necrosis factor-alpha induced enhancement of cryosurgery." In Biomedical Optics (BiOS) 2008, edited by Nikiforos Kollias, Bernard Choi, Haishan Zeng, et al. SPIE, 2008. http://dx.doi.org/10.1117/12.764020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Blanco, A., R. Bonfil, O. Bustoabad, and M. Lazzari. "FACTOR II ACTIVATING ACTIVITY IN EXTRACTS OF TUMORAL NECROSIS FROM TWO MURINE BREAST ADENOCARCINOMAS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643206.

Full text
Abstract:
Increased deposition and lysis of fibrin, associated with malignant tissue, has led to look for activators of both the coagulation and fibrinolytic systems produced by tumor cells. We report the evidences of a procoagblant activity (PA) in the extracts of intratumoral necrosis from two experimental breast adenocarcinomas in murine model (BALB/c). The tumors have different metastatic capacity (MC). M3 without MC and MM3 with high MC.The addition of the extracts to: 1- Normal Plasma, 2- Deficient substrates in coagulation factors, 3- Purified, fibrinogen (I), showed: 1- Shortening of the plasma
APA, Harvard, Vancouver, ISO, and other styles
3

Rivas, MA, M. Tkach, CJ Proietti, et al. "Tumor necrosis factor transactivates ErbB2 in breast cancer cells." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-4056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

abla, hedia ben, Sonia Rekik, Soumaya Boussaid, et al. "AB0699 EFFECT OF SWITCHING BETWEEN TUMOR NECROSIS FACTOR INHIBITOR IN SPONDYLOARTHRITIS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.3834.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pass, Harvey I., Steven Evans, Roger Perry, and Wilbert Matthews. "Kinetics of tumor necrosis factor production by photodynamic-therapy-activated macrophages." In OE/LASE '90, 14-19 Jan., Los Angeles, CA, edited by Thomas J. Dougherty. SPIE, 1990. http://dx.doi.org/10.1117/12.17660.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Laabidi, S., S. Bizid, A. Ben Mahmoud, et al. "Anti-Tumor Necrosis Factor Drug Response in Chronic Inflammatory Bowel Disease and Influencing Factors." In ESGE Days 2021. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1724752.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Huang, Yun-Ju, Yao-Fan Fang, Shue-Fen Luo, et al. "AB0383 LATENT TUBERCULOSIS INFECTION SHOULD BE MONITORED IN BOTH TUMOR NECROSIS FACTOR INHIBITORS AND NON-TUMOR NECROSIS FACTOR INHIBITORS IN BIOLOGICAL-NAïVE PATIENTS WITH RHEUMATOID ARTHRITIS." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.3054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rego, Stephen, Krista Ricci, Muthulekha Swamydas, and Didier Dreau. "Abstract 397: Soluble Tumor Necrosis Factor Receptor shed by breast tumor cells modulates macrophage migration." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-397.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Iwona, Grądzka, Sikorska Katarzyna, and Brzóska Kamil. "Interference of Silver Nanoparticles with Tumor Necrosis Factor Action in Epithelial Cells." In The 2nd World Congress on Recent Advances in Nanotechnology. Avestia Publishing, 2017. http://dx.doi.org/10.11159/icnb17.116.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Membriani, Evangelina, Erika Cuenca, Leticia Limongi, Ana Putruele, and Carlos Luna. "Latent tuberculosis screening and entering antibody therapy monoclonares against tumor necrosis factor." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2701.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Tumor necrosis factor"

1

Larrick, James W., Vera Morhenn, Yawen L. Chiang, and Tim Shi. Activated Langerhans Cells Release Tumor Necrosis Factor. Defense Technical Information Center, 1988. http://dx.doi.org/10.21236/ada206646.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gao, Li-nan, Lian-gang Ge, Ming-zhe Zhu та Xin-xin Yao. Association between tumor necrosis factor α and uterine fibroids: a protocol of systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.7.0010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Li, Peng, and Junjun Liu. Effect of tumor necrosis factor inhibitors on the risk of adverse cardiovascular events in patients with psoriasis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.8.0090.

Full text
Abstract:
Review question / Objective: Previous studies have indicated a cardioprotective effect of tumor necrosis factor inhibitor (TNFi) therapy in adult patients with psoriasis (Pso). However, most were retrospective studies, and the association between cardiometabolic comorbidities and major adverse cardiovascular events (MACE) has not been validated in randomized controlled trials (RCTs). Condition being studied: Because the available evidence has recently increased, we performed the present updated meta-analysis and meta-regression of cohort studies and RCTs to evaluate whether TNFi therapy can de
APA, Harvard, Vancouver, ISO, and other styles
4

Behbakht, Kian. Modulators of Response to Tumor Necrosis-Factor-Related Apoptosis Inducing Ligand (TRAIL) Therapy in Ovarian Cancer. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada532993.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

กาญจนทัต, อภิชาติ. ความเป็นพิษและการเหนี่ยวนำการตายแบบอะโพโทซิสต่อเซลล์มะเร็ง โดยเพปไทด์จากเกสรผึ้งพันธุ์ Apis mellifera. สถาบันวิจัยเทคโนโลยีชีวภาพและวิศวกรรมพันธุศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย, 2018. https://doi.org/10.58837/chula.res.2018.100.

Full text
Abstract:
งานวิจัยนี้เตรียมโปรตีนไฮโดรไลเสตจากเกสรผึ้งพันธุ์ ที่ได้จากปฏิกิริยาย่อยสลายด้วยเอนไซม์ 3 ชนิด ได้แก่ แอลคาเลส ฟลาโวไซม์ และนิวเทรส พบว่าเมื่อใช้นิวเทรสในอัตราส่วนของเอนไซม์ต่อสับสเตรต 1:1 (NH1) โดยปริมาตร จะให้แสดงค่าการยับยั้งการสร้างอนุมูลอิสระด้วยวิธีไนตริกออกไซต์ได้ดีที่สุด คัดแยกเพปไทด์ที่มีขนาดโมเลกุลต่ำกว่า 0.65 กิโลดาลตัน (MW1) มีฤทธิ์ในการขจัดอนุมูลอิสระไนตริกออกไซด์ได้ดีที่สุด จากนั่นได้ทำการตรวจสอบความเป็นพิษของ MW1 ด้วยวิธี MTT และตรวจสอบ ผลการยับยั้งการสร้างไนตริกออกไซด์ในเซลล์แมคโครฟาจ RAW 264.7 ที่ถูกกระตุ้นด้วยไลโปโพลิแซคคาไรด์ พบว่า MW1 ไม่มีความเป็นพิษต่อเซลล์ และมีฤทธิ์ในก
APA, Harvard, Vancouver, ISO, and other styles
6

Borra, Himabindu, Daniel F. Battafarano, Ramon Arroyo, Michael J. Morris, Michelle Sit, and Gerald Merrill. Reliability of Tuberculosis Screening Test in Patients Receiving Tumor Necrosis Factor Antagonist Therapy in a United States Rheumatology Clinic. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada577631.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ni, Xiaofeng, and Lingli Zhang. Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. https://doi.org/10.37766/inplasy2024.12.0012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

พงษ์เลาหพันธุ์, ศุภวิวัธน์, та ธีรพงศ์ ยะทา. การพัฒนาพาหะนำส่งยีนเหนี่ยวนำการตายของเซลล์แบบอะพอพโทซิสระดับนาโน เพื่อการคุมกำเนิดสัตว์เพศผู้แบบไม่ผ่าตัดทำหมัน : ต้นแบบเพื่อการคุมจำนวนประชากรสุนัขและแมวจรจัด. คณะสัตวแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย, 2019. https://doi.org/10.58837/chula.res.2019.42.

Full text
Abstract:
การศึกษาวิจัยนี้มีวัตถุประสงค์ เพื่อตรวจสอบการนำไปใช้ของอนุภาคไคโตซานระดับนาโนที่ถูกดัดแปลงให้มีคุณสมบัติเป็นตัวนำส่งยีนเหนี่ยวนำการตายแบบอะพอพโทซิสเข้าสู่เซลล์อัณฑะที่มีตัวรับฮอร์โมนโกนาโดโทรปินรีลิสซิ่ง โดยการออกแบบตัวนำส่งยีนนี้สามารถนำไปใช้ประโยชน์ในการทำหมันสัตว์เพศผู้แบบไม่ผ่าตัด การศึกษานี้ได้มีการรายงานผลของอนุภาคไคโตซานระดับนาโนเชื่อมติดกับฮอร์โมนโกนาโดโทรปินรีลิสซิ่ง (Gonadotropin Releasing Hormone-modified Chitosan; GnRH-CS) เพื่อนำส่งยีนอย่างมีเป้าหมาย และการใช้เปปไทด์โกนาโดโทรปินรีลิสซิ่งในการระบุเป้าหมายการนำส่งยีนไปสู่เซลล์ที่มีตัวรับฮอร์โมนโกนาโดโทรปินรีลิสซิ่ง (GnRH receptor;
APA, Harvard, Vancouver, ISO, and other styles
9

Dotsenko, S. S., L. N. Shilova, A. S. Trofimenko, S. A. Bedina, E. A. Tikhomirova та M. A. Mamus. The role of cytokines in predicting the effectiveness of combined treatment with tumor necrosis factor α inhibitors in rheumatoid arthritis. ООО "ИМА-Пресс", 2018. http://dx.doi.org/10.18411/1995-4484-2018-56-33-17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Meidan, Rina, and Joy Pate. Roles of Endothelin 1 and Tumor Necrosis Factor-A in Determining Responsiveness of the Bovine Corpus Luteum to Prostaglandin F2a. United States Department of Agriculture, 2004. http://dx.doi.org/10.32747/2004.7695854.bard.

Full text
Abstract:
The corpus luteum (CL) is a transient endocrine gland that has a vital role in the regulation of the estrous cycle, fertility and the maintenance of pregnancy. In the absence of appropriate support, such as occurs during maternal recognition of pregnancy, the CL will regress. Prostaglandin F2a (PGF) was first suggested as the physiological luteolysin in ruminants several decades ago. Yet, the cellular mechanisms by which PGF causes luteal regression remain poorly defined. In recent years it became evident that the process of luteal regression requires a close cooperation between steroidogenic,
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Tumor necrosis factor' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography